Page last updated: 2024-10-30
losartan and MELAS
losartan has been researched along with MELAS in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Rajendran, PR | 1 |
| Molitor, JA | 1 |
Other Studies
1 other study available for losartan and MELAS
| Article | Year |
|---|---|
Resolution of hypertensive encephalopathy and scleroderma renal crisis with an angiotensin receptor blocker.
Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; CADASIL; Female; Humans; Hypertensive | 2005 |